{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:13Z","timestamp":1786989013416,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.euros.2022.12.011","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T12:21:44Z","timestamp":1675081304000},"page":"80-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy"],"prefix":"10.1016","volume":"49","author":[{"given":"Hilda A.","family":"de Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Duin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van der Noort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Arjen","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M.K.","family":"Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris J.","family":"Pos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter V.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva E.","family":"Schaake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fijs W.B.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Grivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk G.","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2022.12.011_b0005","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.juro.2017.12.048","article-title":"Contemporary incidence and outcomes of prostate cancer lymph node metastases","volume":"199","author":"Bernstein","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.06.011","article-title":"The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients","volume":"96","author":"Van Hemelryk","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00066-016-1094-5","article-title":"Whole pelvis radiotherapy for pathological node-positive prostate cancer","volume":"193","author":"Poelaert","year":"2017","journal-title":"Strahlentherapie Und Onkol"},{"key":"10.1016\/j.euros.2022.12.011_b0025","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.radonc.2019.12.006","article-title":"Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): a randomised trial","volume":"145","author":"Murthy","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0035","doi-asserted-by":"crossref","unstructured":"Tharmalingam H, Tsang Y, Choudhury A, Hoskin P. External beam radiotherapy (EBRT) and high dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: whole pelvis or prostate-only EBRT? J Clin Oncol 2018;36:86\u201386.","DOI":"10.1200\/JCO.2018.36.6_suppl.86"},{"key":"10.1016\/j.euros.2022.12.011_b0040","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S1470-2045(18)30528-X","article-title":"Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG\/RTOG 9413): long-term results of a randomised, phase 3 trial","volume":"19","author":"Roach","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0055","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68 Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0060","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.eururo.2009.03.012","article-title":"Pelvic lymph node dissection in prostate cancer","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2012.06.057","article-title":"Mapping of pelvic lymph node metastases in prostate cancer","volume":"63","author":"Joniau","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bju.13810","article-title":"Sentinel node biopsy for prostate cancer: report from a consensus panel meeting","volume":"120","author":"van der Poel","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2022.12.011_b0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.eururo.2016.09.007","article-title":"Sentinel node procedure in prostate cancer: a systematic review to assess diagnostic accuracy","volume":"71","author":"Wit","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","article-title":"The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study","volume":"53","author":"Mattei","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0085","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0090","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.eururo.2011.03.024","article-title":"Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer","volume":"60","author":"van der Poel","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euros.2022.12.011_b0100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euros.2022.12.011_b0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.euros.2022.12.011_b0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2008.10.082","article-title":"Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death","volume":"75","author":"D\u2019Amico","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euros.2022.12.011_b0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4111\/icu.2018.59.1.18","article-title":"Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer","volume":"59","author":"Nam","year":"2018","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijrobp.2016.10.016","article-title":"Sentinel lymph node dissection to select clinically node-negative prostate cancer patients for pelvic radiation therapy: effect on biochemical recurrence and systemic progression","volume":"97","author":"Grivas","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0125","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.10.5171","article-title":"Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01","volume":"25","author":"Pommier","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0130","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1200\/JCO.2003.05.004","article-title":"Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413","volume":"21","author":"Roach","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0135","first-page":"9","article-title":"Nodal recurrence patterns on PET\/CT after RTOG-based nodal radiotherapy for prostate cancer","volume":"22","author":"Liskamp","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.euros.2022.12.011_b0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eururo.2022.06.002","volume":"82","author":"Gandaglia","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2018.03.013","article-title":"99mTechnetium-based prostate-specific membrane antigen\u2013radioguided surgery in recurrent prostate cancer","volume":"75","author":"Maurer","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.12.011_b0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eururo.2022.03.002","article-title":"Robot-assisted prostate-specific membrane antigen\u2013radioguided salvage surgery in recurrent prostate cancer using a DROP-IN gamma probe: the first prospective feasibility study","volume":"82","author":"de Barros","year":"2022","journal-title":"Eur Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168323000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168323000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:08:45Z","timestamp":1762978125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168323000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":30,"alternative-id":["S2666168323000034"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2022.12.011","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2022.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}